Rishon Le-Zion, Israel

Ziv Oren


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2001-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ziv Oren: Innovator in Antipathogenic Peptides

Introduction

Ziv Oren is a notable inventor based in Rishon Le-Zion, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of antipathogenic synthetic peptides. With a total of 2 patents, Oren's work focuses on creating non-hemolytic cytolytic agents that can effectively target pathogenic cells without harming healthy red blood cells.

Latest Patents

Oren's latest patents include innovative formulations of antipathogenic synthetic peptides and compositions comprising them. The first patent describes non-hemolytic cytolytic agents selected from peptides, complexes of bundled peptides, mixtures of peptides, or random peptide copolymers. These agents exhibit cytolytic activity specifically against pathogenic cells, including microbial organisms and malignant cells, while remaining non-hemolytic. The peptides may be cyclic derivatives of natural peptides such as pardaxin and mellitin, with modifications that enhance their efficacy. The second patent focuses on peptides with a net positive charge and a partial α-helix configuration, which also demonstrate selective cytolytic activity. These peptides can be utilized in pharmaceutical compositions for treating various diseases caused by pathogens, including bacterial, fungal, viral, and protozoan infections, as well as cancer.

Career Highlights

Ziv Oren is associated with Yeda Research and Development Co. Ltd., where he continues to advance his research in the field of antipathogenic peptides. His work has the potential to revolutionize treatment options for infectious diseases and cancer, showcasing his commitment to innovation in biotechnology.

Collaborations

Oren collaborates with Yechiel Shai, contributing to the development of groundbreaking therapeutic solutions. Their partnership exemplifies the collaborative spirit in scientific research, driving forward the boundaries of knowledge and application in the field.

Conclusion

Ziv Oren's contributions to the field of antipathogenic peptides highlight his innovative spirit and dedication to improving healthcare solutions. His patents represent significant advancements in biotechnology, with the potential to impact the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…